APA (7th ed.) Citation

R, W., K, V., T, P., L, K., M, A., AL, F., . . . S, D. (2026). Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis. JCI insight, 11(4), . https://doi.org/10.1172/jci.insight.196812

Chicago Style (17th ed.) Citation

R, Weyer, et al. "Pathophysiological and Therapeutic Implications of C-type Natriuretic Peptide/cyclic GMP Signaling in Pulmonary Fibrosis." JCI Insight 11, no. 4 (2026). https://doi.org/10.1172/jci.insight.196812.

MLA (9th ed.) Citation

R, Weyer, et al. "Pathophysiological and Therapeutic Implications of C-type Natriuretic Peptide/cyclic GMP Signaling in Pulmonary Fibrosis." JCI Insight, vol. 11, no. 4, 2026, https://doi.org/10.1172/jci.insight.196812.